An Updated Mini-Review on Adverse Effects of Second-Generation Glycopeptide Antibiotics: Telavancin, Dalbavancin and Oritavancin
Crossref DOI link: https://doi.org/10.1007/s10989-025-10694-2
Published Online: 2025-02-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yan, Zixuan
Chen, Hui
Zeng, Ping
Liu, Wei
Text and Data Mining valid from 2025-02-03
Version of Record valid from 2025-02-03
Article History
Accepted: 21 January 2025
First Online: 3 February 2025
Declarations
:
: The authors declare no competing interests.